Ignite Creation Date:
2025-12-24 @ 4:08 PM
Ignite Modification Date:
2026-01-25 @ 1:52 AM
Study NCT ID:
NCT00645866
Status:
COMPLETED
Last Update Posted:
2011-05-16
First Post:
2008-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer
Sponsor:
Mayo Clinic
Organization: